Content
The BD Vacutainer® product family enhances sample quality while helping protect nurses, phlebotomists and other caregivers from costly accidental needlestick injuries. The brand also helps reduce retests, recollects and instrument downtime to improve lab productivity and workflow. The BD Interventional segment focuses on developing innovative surgical, endovascular, urological and critical care interventions that not only meet clinical needs but also deliver value to health systems and improve patients’ lives. Our customers include hospitals and clinics; physicians; ambulatory surgery centers; nurses; and consumers. BD Synapsys™ solution enables laboratories to address challenges and improve laboratory outcomes.
Investors
2020 BD launched the first sample preparation and flow cytometry system to enable clinical laboratories to fully automate the sample-to-answer process. Our comprehensive portfolio is backed by our leading-edge science, innovation technology, proven expertise and support services, enabling you to address your ongoing clinical and operational needs. The BD Phoenix™ M50 instrument provides clinicians with accurate and timely identification and susceptibility results to help guide their therapy and patient management decisions. BD Phoenix™ panels provide accurate, rapid identification and susceptibility results for most clinically significant aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria, as well as identification of yeast and yeast-like organisms. Delivering efficiency, flexibility, and performance to meet your laboratories’ evolving molecular diagnostic needs.
Help advance care for patients throughout their diagnostic journey, while also addressing your testing needs
About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues.
Bard might be a scam, please verify by searching for the posting on the careers page or contact us at For more information click here. Clicking on the link may allow third parties to collect or share data about you. “Jack” Howe joins BD and becomes integral to developing sterility control procedures and refining the process for manufacturing disposable syringes and needles.
BD Integrated Diagnostic Solutions
Where the website is managed by another BD company, please note that it may be governed by different laws and policies, and may feature products and services that are not available locally. 1995 BD formed a subsidiary in India to manufacture insulin syringes and to market other medical and diagnostic products to the region. 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.
Together We Advance
BD Kiestra™ laboratory automation solutions are uniquely positioned to offer standardized and scalable solutions for inoculation, incubation, plate imaging and reading and follow-up testing. BD Kiestra™ solutions help prepare laboratories to meet these changing https://betinwin-bd.com/ demands and achieve efficient, timely and cost-effective clinical bacteriological testing. Where the website is managed by another BD company, please note that it may be governed by different laws and policies and may feature products and services that are not available locally. Please contact your local BD representative if you have any questions or should you require further support.